Over 10,000 Hematopoietic Stem Cell Transplants: A Milestone in Medical Innovation!

On April 19th, 2024, Beijing’s Ludaopei Hospital successfully performed its 10,000th hematopoietic stem cell transplant, a remarkable achievement after just 12 years. This accomplishment places Ludaopei Medical Group among the fastest institutions in the world to reach this milestone. This achievement not only represents a significant medical breakthrough but also symbolizes a new life for countless families battling hematological diseases.

A Legacy of Excellence

Ludaopei Medical Group’s founder, Professor Ludaopei, pioneered hematopoietic stem cell transplants in Asia, completing the first such transplant in 1964. Over the years, the group’s leadership in the field, bolstered by innovative treatments and research, has propelled it to international prominence.

From 1 to 10,000 Transplants

In 2012, the Ludaopei Medical Group was founded, marking a new era in hematology and stem cell transplantation. The group’s achievements include pioneering stem cell transplants for rare diseases, including lymphoma and leukemia, as well as various high-risk cases. The group’s clinical successes have earned recognition from patients worldwide.

The transplant success stories range from children as young as 2 months to elderly patients up to 73 years old, underscoring the group's expertise in treating complex cases, including rare diseases like familial hemophagocytic lymphohistiocytosis and severe immunodeficiencies.

Looking Ahead: A New Chapter

The milestone of 10,000 transplants is just the beginning. Moving forward, the group is committed to further advancements, including exploring cutting-edge therapies such as CAR-T cell therapy. With continuous growth and new breakthroughs, the Ludaopei Medical Group aims to bring hope to more patients and contribute to the global advancement of hematological treatment.